VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,972 | -46.4% | 57,864 | -18.2% | 0.00% | – |
| Q2 2023 | $466,025 | +39.0% | 70,717 | +43.3% | 0.00% | – |
| Q1 2023 | $335,168 | -8.1% | 49,362 | +0.0% | 0.00% | – |
| Q4 2022 | $364,674 | -35.6% | 49,347 | -13.9% | 0.00% | -100.0% |
| Q3 2022 | $566,000 | -8.9% | 57,324 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $621,000 | -9.2% | 57,002 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $684,000 | -29.0% | 60,484 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $964,000 | -8.1% | 61,401 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $1,049,000 | -19.5% | 61,177 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $1,303,000 | +29.7% | 60,568 | -9.4% | 0.00% | 0.0% |
| Q1 2021 | $1,005,000 | -13.5% | 66,886 | -24.4% | 0.00% | 0.0% |
| Q4 2020 | $1,162,000 | +12.8% | 88,465 | -17.0% | 0.00% | 0.0% |
| Q3 2020 | $1,030,000 | -22.3% | 106,619 | -7.9% | 0.00% | 0.0% |
| Q2 2020 | $1,325,000 | +237.2% | 115,780 | +205.0% | 0.00% | – |
| Q1 2020 | $393,000 | -49.0% | 37,958 | -19.2% | 0.00% | -100.0% |
| Q4 2019 | $770,000 | +52.8% | 46,968 | +23.7% | 0.00% | – |
| Q3 2019 | $504,000 | -25.7% | 37,977 | -21.1% | 0.00% | -100.0% |
| Q2 2019 | $678,000 | -48.4% | 48,127 | -32.6% | 0.00% | 0.0% |
| Q1 2019 | $1,314,000 | +19.8% | 71,393 | +70.2% | 0.00% | 0.0% |
| Q4 2018 | $1,097,000 | +61.3% | 41,941 | +41.3% | 0.00% | 0.0% |
| Q3 2018 | $680,000 | -43.3% | 29,672 | -52.9% | 0.00% | 0.0% |
| Q2 2018 | $1,199,000 | +52.2% | 63,001 | +34.7% | 0.00% | 0.0% |
| Q1 2018 | $788,000 | +25.5% | 46,758 | +13.1% | 0.00% | 0.0% |
| Q4 2017 | $628,000 | -34.7% | 41,327 | -23.0% | 0.00% | 0.0% |
| Q3 2017 | $961,000 | +31.8% | 53,676 | +20.0% | 0.00% | 0.0% |
| Q2 2017 | $729,000 | -75.6% | 44,734 | -79.1% | 0.00% | -66.7% |
| Q1 2017 | $2,993,000 | +0.6% | 213,808 | +14.6% | 0.00% | 0.0% |
| Q4 2016 | $2,975,000 | -10.1% | 186,556 | -6.3% | 0.00% | 0.0% |
| Q3 2016 | $3,311,000 | +183.2% | 199,045 | +90.5% | 0.00% | +200.0% |
| Q2 2016 | $1,169,000 | +66.3% | 104,487 | +24.2% | 0.00% | 0.0% |
| Q1 2016 | $703,000 | +95.8% | 84,121 | +118.0% | 0.00% | – |
| Q4 2015 | $359,000 | +8.8% | 38,596 | +32.1% | 0.00% | – |
| Q3 2015 | $330,000 | -86.9% | 29,218 | -85.3% | 0.00% | -100.0% |
| Q2 2015 | $2,527,000 | +227.8% | 199,072 | +140.4% | 0.00% | +100.0% |
| Q1 2015 | $771,000 | -31.9% | 82,797 | +4.7% | 0.00% | 0.0% |
| Q4 2014 | $1,132,000 | +246.2% | 79,044 | +151.1% | 0.00% | – |
| Q3 2014 | $327,000 | -13.0% | 31,474 | +35.5% | 0.00% | – |
| Q2 2014 | $376,000 | -71.7% | 23,235 | -71.6% | 0.00% | -100.0% |
| Q1 2014 | $1,327,000 | +163.3% | 81,680 | +101.0% | 0.00% | – |
| Q4 2013 | $504,000 | +55.6% | 40,645 | +37.2% | 0.00% | – |
| Q3 2013 | $324,000 | +29.6% | 29,616 | -4.4% | 0.00% | – |
| Q2 2013 | $250,000 | +431.9% | 30,987 | +156.7% | 0.00% | – |
| Q1 2013 | $47,000 | – | 12,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |